Scott Gottlieb Expects the FDA to Approve 40 Gene Therapies by 2022

FDA commissioner, Scott Gottlieb said that he expects the FDA to approve 40 gene therapies by 2022 in a fireside chat at the 2018 BIO International Convention.

Gottlieb was interviewed by BIO president and CEO, Jim Greenwood as the event was wrapping up yesterday, and told him that we might see cures for diseases like sickle cell anaemia within 10 years.